3 Ways to Safely Accelerate Your Clinical Document Submissions
Watch this video to find out how we can help with EU CTR.
02:15 – Learn about the tech behind the solutions
03:55 – Find out which solution is right for you
07:45 – Watch a demo of Mirage software
With increasing pressure to protect commercially confidential information (CCI) – and mandatory compliance with EU Clinical Trials Regulation (EU CTR) coming on January 31, 2023 – now is the time to act.
Do you have a plan for handling these increased transparency demands on top of existing requirements under Health Canada Public Release of Clinical Information (PRCI) and future requirements under EMA Policy 0070?
If not, there are three ways Privacy Analytics can help you safely accelerate submissions while protecting personal information – and CCI – throughout the clinical trial lifecycle.
Contact us to learn about our CCI protection services and find out which solution best meets your most pressing clinical document submission needs: Redaction-as-a-Service, Anonymization-as-a-Service, or a software license option.
Send us a message using the form below and we’ll be in touch soon.
Your message is being reviewed and one of our experts will be in touch shortly.
Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.
Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.
Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.
Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.
Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.
This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.